157 related articles for article (PubMed ID: 33331873)
1. Intravitreal Anti-Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic.
Billioti de Gage S; Drouin J; Desplas D; Cuenot F; Dray-Spira R; Weill A; Zureik M
JAMA Ophthalmol; 2021 Feb; 139(2):240-242. PubMed ID: 33331873
[TBL] [Abstract][Full Text] [Related]
2. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients.
Parikh R; Ross JS; Sangaralingham LR; Adelman RA; Shah ND; Barkmeier AJ
Ophthalmology; 2017 Mar; 124(3):352-358. PubMed ID: 27890437
[TBL] [Abstract][Full Text] [Related]
3. Variation in Ophthalmologist Use of Antivascular Endothelial Growth Factor Therapy Among Medicare Beneficiaries.
Thakore RV; Greenberg PB; Behrens JJ; French DD
JAMA Ophthalmol; 2016 Sep; 134(9):1071-2. PubMed ID: 27366859
[No Abstract] [Full Text] [Related]
4. Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center.
Juncal VR; Francisconi CLM; Altomare F; Chow DR; Giavedoni LR; Muni RH; Berger AR; Wong DT
Ophthalmologica; 2019; 242(1):1-7. PubMed ID: 30928983
[TBL] [Abstract][Full Text] [Related]
5. Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update.
Korobelnik JF; Loewenstein A;
Graefes Arch Clin Exp Ophthalmol; 2021 Mar; 259(3):795-797. PubMed ID: 33415358
[No Abstract] [Full Text] [Related]
6. Effects of intravitreal aflibercept and ranibizumab on retinal vessel diameter measured using fluorescein angiography.
Min JK; Lee S; Park JH; Woo JM; Yang HS
Acta Ophthalmol; 2018 Jun; 96(4):e546-e547. PubMed ID: 29068524
[No Abstract] [Full Text] [Related]
7. Characteristics and Outcomes of Full-thickness Macular Hole Repair in Patients Receiving Anti-VEGF Injections for Neovascular Age-related Macular Degeneration.
Ringeisen AL; Parke DW; Dev S
Int Ophthalmol Clin; 2019; 59(1):127-135. PubMed ID: 30585922
[No Abstract] [Full Text] [Related]
8. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
[TBL] [Abstract][Full Text] [Related]
9. Aflibercept anti-vascular endothelial growth factor therapy in vitrectomized eyes with neovascular age-related macular degeneration.
Jung JJ; Hoang QV; Arain MZ; Chang S
Acta Ophthalmol; 2016 May; 94(3):e249-50. PubMed ID: 26401896
[No Abstract] [Full Text] [Related]
10. ULTRASONOGRAPHIC FINDINGS IN THE VITREOUS OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
Mato-Gondelle T; Bande MF; Paniagua L; Rodríguez-Cid MJ; Abraldes M; Fernández M; Blanco-Teijeiro MJ; Piñeiro A
Retina; 2018 Oct; 38(10):1962-1967. PubMed ID: 28820850
[TBL] [Abstract][Full Text] [Related]
11. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
[TBL] [Abstract][Full Text] [Related]
12. Anti-Vascular Endothelial Growth Factor Intravitreal Therapy and Macular Ganglion Cell Layer Thickness in Patients with Neovascular Age-Related Macular Degeneration.
Abdolrahimzadeh S; Gharbiya M; Formisano M; Bertini F; Cerini A; Pacella E
Curr Eye Res; 2019 Sep; 44(9):1000-1005. PubMed ID: 30999772
[No Abstract] [Full Text] [Related]
13. Anti-vascular endothelial growth factor for unilateral acute idiopathic maculopathy.
Mylonas G; Prager F; Wetzel B; Malamos P; Deak G; Amon M
Eur J Ophthalmol; 2018 Mar; 28(2):256-258. PubMed ID: 29108393
[TBL] [Abstract][Full Text] [Related]
14. Increased Number of Submacular Hemorrhages as a Consequence of Coronavirus Disease 2019 Lockdown.
Romano F; Monteduro D; Airaldi M; Zicarelli F; Parrulli S; Cozzi M; Staurenghi G
Ophthalmol Retina; 2020 Dec; 4(12):1209-1210. PubMed ID: 32593777
[No Abstract] [Full Text] [Related]
15. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Borkar DS; Obeid A; Su DC; Storey PP; Gao X; Regillo CD; Kaiser RS; Garg SJ; Hsu J;
Am J Ophthalmol; 2018 Oct; 194():1-6. PubMed ID: 29981738
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.
Nomura Y; Yanagi Y
Jpn J Ophthalmol; 2015 Jul; 59(4):261-5. PubMed ID: 25983109
[TBL] [Abstract][Full Text] [Related]
17. Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept.
Forooghian F; Albiani DA; Kirker AW; Merkur AB
Can J Ophthalmol; 2017 Dec; 52(6):616-619. PubMed ID: 29217032
[TBL] [Abstract][Full Text] [Related]
18. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
Stathopoulos C; Gaillard MC; Moulin A; Puccinelli F; Beck-Popovic M; Munier FL
Retina; 2019 Dec; 39(12):2273-2282. PubMed ID: 30312257
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab.
Papakostas TD; Lim L; van Zyl T; Miller JB; Modjtahedi BS; Andreoli CM; Wu D; Young LH; Kim IK; Vavvas DG; Esmaili DD; Husain D; Eliott D; Kim LA
Eye (Lond); 2016 Jan; 30(1):79-84. PubMed ID: 26449196
[TBL] [Abstract][Full Text] [Related]
20. Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration.
Eng VA; Rayess N; Nguyen HV; Leng T
PLoS One; 2020; 15(5):e0232353. PubMed ID: 32369500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
